Cocaine Addiction Clinical Trial
Official title:
A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/Week or 300 mg/Week) as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
The primary objective of this study is to assess the efficacy and safety of TV-1380 [Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)] in facilitating abstinence in cocaine-dependent subjects.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04336293 -
sTMS for Substance Use-disordered Veterans
|
N/A | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT01822587 -
Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving
|
Phase 2 | |
Completed |
NCT01601743 -
Exercise as a Behavioral Treatment for Cocaine Dependence
|
N/A | |
Completed |
NCT02563769 -
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
|
Phase 1 | |
Completed |
NCT01651377 -
Pramipexole as a Treatment for Cocaine Dependence
|
Phase 1 | |
Completed |
NCT02768441 -
Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots
|
Early Phase 1 | |
Completed |
NCT02626494 -
Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction
|
Phase 4 | |
Recruiting |
NCT02892851 -
Deep Brain Stimulation of the Sub-Thalamic Nucleus to Treat Severe and Treatment-resistant Cocaine Addiction.
|
N/A | |
Not yet recruiting |
NCT01319214 -
Reducing Drug Craving Memories
|
N/A | |
Recruiting |
NCT01259362 -
Effects of Repeated Transcranial Magnetic Stimulation (rTMS) on the Treatment of Cocaine Addicted Patients
|
Phase 2 | |
Completed |
NCT01211418 -
Integrative Meditation (IM) for Cocaine Addiction
|
N/A | |
Recruiting |
NCT03423667 -
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
|
Phase 2 | |
Completed |
NCT01984177 -
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
|
N/A | |
Completed |
NCT01337297 -
Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction
|
Phase 1/Phase 2 | |
Completed |
NCT01067846 -
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
|
N/A | |
Completed |
NCT01651364 -
A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence
|
Phase 1 | |
Recruiting |
NCT03018236 -
Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
|
Phase 4 | |
Completed |
NCT01929343 -
Lidocaine Infusion as a Treatment for Cocaine Relapse and Craving
|
Phase 2 | |
Completed |
NCT01281202 -
Vigabatrin for the Treatment of Cocaine Dependency
|
Phase 2/Phase 3 |